On July 25, 2025, BioNTech SE and Pfizer Inc. announced that the European Medicines Agency's CHMP recommended marketing authorization for their LP.8.1-adapted COVID-19 vaccine for individuals 6 months and older.
AI Assistant
BIONTECH SE
2025
6 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.